Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A De Man

Showing results (181-190 of 543) with videos related to

Pageof 55
Sort By:
Rheumatology Advances in Practice|April 21, 2025
Improving efficiency of a rheumatology outpatient clinic through classification of newly referred patientsSander Dijkstra, Yaël A de Man, Aleida Braaksma, et al.
Journal of Clinical Microbiology|February 22, 2008
Comparison of reverse hybridization, microarray, and sequence analysis for genotyping hepatitis B virusSuzan D Pas, Nathalie Tran, Robert A de Man, et al.
The Journal of Infectious Diseases|May 21, 1998
Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatmentH G Niesters, P Honkoop, E B Haagsma, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 12, 2018
Bacterascites: A study of clinical features, microbiological findings, and clinical significanceRosalie C Oey, Henk R van Buuren, David M de Jong, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2011
Can a decision-making model be justified in the management of hepatocellular adenoma?Susanna M van Aalten, Caroline D M Witjes, Robert A de Man, et al.
The Netherlands Journal of Medicine|December 31, 2020
Fendrix® compared to Engerix® in HIV-infected patients nonresponding to initial- and re-vaccination scheduleT E M S de Vries-Sluijs, E R Andrinopoulou, R A de Man, et al.
Journal of Viral Hepatitis|May 16, 2002
Passive immunization of chronic hepatitis B patients on lamivudine therapy: a feasible issue?A B van Nunen, R A de Man, R A Heijtink, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 29, 2020
New insights in the management of Hepatocellular AdenomaAnne J Klompenhouwer, Robert A de Man, Marco Dioguardi Burgio, et al.
FEMS Immunology and Medical Microbiology|October 15, 2003
The intrahepatic immune response during chronic hepatitis B infection can be monitored by the fine-needle aspiration biopsy techniqueThjon J Tang, Harry L A Janssen, Johannes G Kusters, et al.
Journal of Medical Virology|July 27, 2001
Administration of a human monoclonal antibody (TUVIRUMAB) to chronic hepatitis B patients pre-treated with lamivudine: monitoring of serum TUVIRUMAB in immune complexesR A Heijtink, A B van Nunen, P van Bergen, et al.
Pageof 55

Showing results (181-190 of 543) with videos related to

Sort By:
Pageof 55
Rheumatology Advances in Practice|April 21, 2025
Improving efficiency of a rheumatology outpatient clinic through classification of newly referred patientsSander Dijkstra, Yaël A de Man, Aleida Braaksma, et al.
Journal of Clinical Microbiology|February 22, 2008
Comparison of reverse hybridization, microarray, and sequence analysis for genotyping hepatitis B virusSuzan D Pas, Nathalie Tran, Robert A de Man, et al.
The Journal of Infectious Diseases|May 21, 1998
Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatmentH G Niesters, P Honkoop, E B Haagsma, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 12, 2018
Bacterascites: A study of clinical features, microbiological findings, and clinical significanceRosalie C Oey, Henk R van Buuren, David M de Jong, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2011
Can a decision-making model be justified in the management of hepatocellular adenoma?Susanna M van Aalten, Caroline D M Witjes, Robert A de Man, et al.
The Netherlands Journal of Medicine|December 31, 2020
Fendrix® compared to Engerix® in HIV-infected patients nonresponding to initial- and re-vaccination scheduleT E M S de Vries-Sluijs, E R Andrinopoulou, R A de Man, et al.
Journal of Viral Hepatitis|May 16, 2002
Passive immunization of chronic hepatitis B patients on lamivudine therapy: a feasible issue?A B van Nunen, R A de Man, R A Heijtink, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 29, 2020
New insights in the management of Hepatocellular AdenomaAnne J Klompenhouwer, Robert A de Man, Marco Dioguardi Burgio, et al.
FEMS Immunology and Medical Microbiology|October 15, 2003
The intrahepatic immune response during chronic hepatitis B infection can be monitored by the fine-needle aspiration biopsy techniqueThjon J Tang, Harry L A Janssen, Johannes G Kusters, et al.
Journal of Medical Virology|July 27, 2001
Administration of a human monoclonal antibody (TUVIRUMAB) to chronic hepatitis B patients pre-treated with lamivudine: monitoring of serum TUVIRUMAB in immune complexesR A Heijtink, A B van Nunen, P van Bergen, et al.
Pageof 55